FDA 483 - DR. NELSON E. UZQUIANO - September 11, 2020

An FDA inspection of Nelson E. Uzquiano, M.D., a clinical investigator in Houston, TX, revealed a significant failure to personally supervise an investigation. The investigator did not adequately evaluate abnormal subject findings, ensure recommended follow-ups, or report adverse events as required by the investigational plan and protocol. These deficiencies indicate a lack of proper oversight in the conduct of clinical trials.